STAAR Surgical Company (STAA)
Return on total capital
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Earnings before interest and tax (EBIT) | US$ in thousands | 28,097 | 43,802 | 33,339 | 6,769 | 11,852 |
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 385,954 | 336,112 | 261,568 | 197,222 | 159,884 |
| Return on total capital | 7.28% | 13.03% | 12.75% | 3.43% | 7.41% |
December 31, 2023 calculation
Return on total capital = EBIT ÷ (Long-term debt + Total stockholders’ equity)
= $28,097K ÷ ($—K + $385,954K)
= 7.28%
STAAR Surgical Company's return on total capital has fluctuated over the past five years. In 2023, the return on total capital was 7.28%, a decrease from the prior year's 13.03%. This decline may indicate a decrease in efficiency in generating profits from the company's total capital.
Comparing to the 2021 and 2020 figures, where the return on total capital was 12.75% and 3.43% respectively, the company showed relatively better performance in 2023. However, it is noteworthy that the return on total capital in 2019 was 7.41%, which is comparable to the 2023 figure.
Further analysis would be required to understand the factors contributing to the fluctuations in the return on total capital and evaluate the company's overall capital management efficiency.
Peer comparison
Dec 31, 2023